Annual Cash & Cash Equivalents
$5.57 M
-$14.40 M-72.11%
December 31, 2023
Summary
- As of February 7, 2025, RDHL annual cash & cash equivalents is $5.57 million, with the most recent change of -$14.40 million (-72.11%) on December 31, 2023.
- During the last 3 years, RDHL annual cash & cash equivalents has fallen by -$23.73 million (-80.99%).
- RDHL annual cash & cash equivalents is now -89.65% below its all-time high of $53.79 million, reached on December 31, 2016.
Performance
RDHL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$7.28 M
+$281.00 K+4.02%
June 1, 2024
Summary
- As of February 7, 2025, RDHL quarterly cash and cash equivalents is $7.28 million, with the most recent change of +$281.00 thousand (+4.02%) on June 1, 2024.
- Over the past year, RDHL quarterly cash and cash equivalents has increased by +$281.00 thousand (+4.02%).
- RDHL quarterly cash and cash equivalents is now -91.08% below its all-time high of $81.61 million, reached on March 31, 2020.
Performance
RDHL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RDHL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.1% | +4.0% |
| 3 y3 years | -81.0% | +4.0% |
| 5 y5 years | -80.8% | +4.0% |
RDHL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -81.1% | at low | -75.3% | +4.0% |
| 5 y | 5-year | -81.1% | at low | -91.1% | +4.0% |
| alltime | all time | -89.7% | at low | -91.1% | +112.5% |
RedHill Biopharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $7.28 M(+4.0%) |
| Dec 2023 | $5.57 M(-72.1%) | - |
| Jun 2023 | - | $7.00 M(-60.2%) |
| Mar 2023 | - | $17.57 M(-12.0%) |
| Dec 2022 | $19.97 M(-32.3%) | $19.97 M(+31.3%) |
| Sep 2022 | - | $15.20 M(-43.7%) |
| Jun 2022 | - | $26.99 M(-6.4%) |
| Mar 2022 | - | $28.85 M(-2.1%) |
| Dec 2021 | $29.47 M(+0.6%) | $29.47 M(+26.7%) |
| Sep 2021 | - | $23.25 M(-55.1%) |
| Jun 2021 | - | $51.82 M(-31.8%) |
| Mar 2021 | - | $75.97 M(+159.3%) |
| Dec 2020 | $29.30 M(+0.9%) | $29.30 M(+11.8%) |
| Sep 2020 | - | $26.20 M(+17.6%) |
| Jun 2020 | - | $22.27 M(-72.7%) |
| Mar 2020 | - | $81.61 M(+181.2%) |
| Dec 2019 | $29.02 M(+0.1%) | $29.02 M(+149.5%) |
| Sep 2019 | - | $11.63 M(+29.3%) |
| Jun 2019 | - | $8.99 M(-60.9%) |
| Mar 2019 | - | $23.01 M(-20.7%) |
| Dec 2018 | $29.00 M | $29.00 M(+55.2%) |
| Sep 2018 | - | $18.68 M(+235.8%) |
| Jun 2018 | - | $5.56 M(-26.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $7.56 M(-54.1%) |
| Dec 2017 | $16.45 M(-69.4%) | $16.45 M(-11.8%) |
| Sep 2017 | - | $18.66 M(+21.8%) |
| Jun 2017 | - | $15.32 M(-48.3%) |
| Mar 2017 | - | $29.62 M(-44.9%) |
| Dec 2016 | $53.79 M(+150.0%) | $53.79 M(+694.2%) |
| Sep 2016 | - | $6.77 M(+97.8%) |
| Jun 2016 | - | $3.42 M(-71.5%) |
| Mar 2016 | - | $12.03 M(-44.1%) |
| Dec 2015 | $21.52 M(+265.2%) | $21.52 M(-54.8%) |
| Sep 2015 | - | $47.58 M(+539.6%) |
| Jun 2015 | - | $7.44 M(-12.2%) |
| Mar 2015 | - | $8.47 M(+43.8%) |
| Dec 2014 | $5.89 M(-50.3%) | $5.89 M(-50.9%) |
| Sep 2014 | - | $12.01 M(-30.0%) |
| Jun 2014 | - | $17.14 M(-54.2%) |
| Mar 2014 | - | $37.41 M(+215.7%) |
| Dec 2013 | $11.85 M(-29.5%) | $11.85 M(-10.0%) |
| Sep 2013 | - | $13.16 M(-7.1%) |
| Jun 2013 | - | $14.18 M(-9.9%) |
| Mar 2013 | - | $15.73 M(-6.5%) |
| Dec 2012 | $16.81 M(+19.5%) | $16.81 M(+75.6%) |
| Sep 2012 | - | $9.57 M(-32.0%) |
| Dec 2011 | $14.07 M | $14.07 M |
FAQ
- What is RedHill Biopharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for RedHill Biopharma?
- What is RedHill Biopharma annual cash & cash equivalents year-on-year change?
- What is RedHill Biopharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for RedHill Biopharma?
- What is RedHill Biopharma quarterly cash and cash equivalents year-on-year change?
What is RedHill Biopharma annual cash & cash equivalents?
The current annual cash & cash equivalents of RDHL is $5.57 M
What is the all time high annual cash & cash equivalents for RedHill Biopharma?
RedHill Biopharma all-time high annual cash & cash equivalents is $53.79 M
What is RedHill Biopharma annual cash & cash equivalents year-on-year change?
Over the past year, RDHL annual cash & cash equivalents has changed by -$14.40 M (-72.11%)
What is RedHill Biopharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RDHL is $7.28 M
What is the all time high quarterly cash and cash equivalents for RedHill Biopharma?
RedHill Biopharma all-time high quarterly cash and cash equivalents is $81.61 M
What is RedHill Biopharma quarterly cash and cash equivalents year-on-year change?
Over the past year, RDHL quarterly cash and cash equivalents has changed by +$281.00 K (+4.02%)